Carsodal en es it fr

Carsodal Brand names, Carsodal Analogs

Carsodal Brand Names Mixture

  • No information avaliable

Carsodal Chemical_Formula


Carsodal RX_link

Carsodal fda sheet

Carsodal msds (material safety sheet)

Carsodal Synthesis Reference

Berger, Ludwig, U.S. Pat. 2,937,119 (1960)

Carsodal Molecular Weight

260.33 g/mol

Carsodal Melting Point

92-93 oC

Carsodal H2O Solubility

0.3 mg/ml

Carsodal State


Carsodal LogP


Carsodal Dosage Forms


Carsodal Indication

For the relief of discomfort associated with acute, painful, musculoskeletal conditions.

Carsodal Pharmacology

Carisoprodol is used as a skeletal muscle relaxant. One of its metabolites, meprobamate, is available as an anxiolytic agent.

Carsodal Absorption

No information avaliable

Carsodal side effects and Toxicity

Symptoms of overdose include drowsiness, giddiness, nausea, indigestion, or rash. Other adverse effects attributed to therapeutic use of carisoprodol include dizziness, irritability, insomnia, diplopia, temporary loss of vision, ataxia, weakness, headache, and dysarthria. Non-CNS adverse effects include gastrointestinal complaints, tachycardia, and postural hypotension. Patients sensitive to sulfites or tartrazine may experience wheezing, allergic rashes including erythema multiforme, or anaphylaxis after using some preparations of carisoprodol which contain such additives

Carsodal Patient Information

Carisoprodol is a muscle relaxant used to relieve the pain and stiffness of muscle spasms and discomfort due to strain and sprain. Inform your physician if you are pregnant or nursing. Do not take this medication with a monoamine oxidase inhibitor. This medication may cause dizziness, drowsiness, or blurred vision; use caution while driving or operating hazardous machinery. Do not take any other sedating drugs or drink alcohol while taking carisoprodol. If dizziness occurs, avoid sudden changes in posture. Take this medication with food to avoid stomach upset. Notify your physician if you develop trouble breathing, unexplained fever, severe weakness, vision changes, swelling, or skin rash. Withdrawal symptoms may occur if therapy is suddenly stopped in a patient on long-term or high-dose therapy.

Carsodal Organisms Affected

Humans and other mammals